ArticleCureus2025
Ultrasound-Guided Percutaneous Lavage for the Treatment of Calcific Tendinopathy of the Supraspinatus: A Comprehensive Approach.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcific tendinopathy of the supraspinatus is a common shoulder condition, characterized by calcium deposits in the supraspinatus tendon, part of the rotator cuff. This condition leads to pain, functional limitations, and a reduced quality of life. Its etiology is multifactorial, involving degenerative processes, metabolic alterations, and biomechanical factors. Ultrasound-guided percutaneous lavage (UGPL) is an emerging treatment option to remove calcium deposits and restore function. The shoulder joint's anatomy is intricate, and calcific tendinopathy primarily affects the supraspinatus tendon, causing impingement and pain. Pathophysiologically, calcific tendinopathy is thought to involve fibrocartilaginous metaplasia, where tendon cells transform into cartilage-like cells, facilitating calcium deposition. The condition progresses through three stages: pre-calcific, calcific, and post-calcific, with varying symptoms and responses to treatment. Epidemiologically, calcific tendinopathy of the rotator cuff is more prevalent in individuals aged 30-50 and is often linked with other medical conditions, such as diabetes and cardiovascular diseases. Diagnosis is typically confirmed through imaging, including radiographs, ultrasound, and magnetic resonance imaging. While conservative treatments such as non-steroidal anti-inflammatory drugs, physical therapy, and shockwave therapy are effective for many patients, some cases require more invasive interventions. UGPL is a minimally invasive procedure that has demonstrated good short- and medium-term outcomes. This technique, which involves needle insertion into the calcified deposits under ultrasound guidance to fragment and aspirate the calcium, offers significant symptomatic relief and restores shoulder function. However, challenges remain, particularly with dense or small calcifications, and the long-term effectiveness of the procedure is still uncertain. Calcific tendinopathy of the rotator cuff requires a personalized treatment approach. UGPL has shown promise as an effective and safe option for patients who do not respond to conservative treatments, such as rehabilitation programs. However, further research is needed to refine treatment protocols, improve patient selection, and assess the long-term efficacy of the procedure. A multidisciplinary approach is essential to optimize patient outcomes and manage this challenging condition effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.